alexa Intravitreal Ranibizumab for Macular Edema Secondary t
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Intravitreal Ranibizumab for Macular Edema Secondary to Juxtafoveal Retinal Telangiectasia Type 1A

Ruwan A. Silva1 and Ninel Z. Gregori1,2*
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
2Clinical Ophthalmology Bascom Palmer Eye Institute, University of Miami Miller School of Medicine Chief of Ophthalmology Section, Miami VA Medical Center, Miami, USA
Corresponding Author : Ninel Gregori, MD
Assistant Professor of Clinical Ophthalmology Bascom Palmer Eye Institute
University of Miami Miller School of Medicine Chief of Ophthalmology Section
Miami VA Medical Center, Miami, USA
Tel: 305-326-6000, 305-575-7000; Ext: 4592
E-mail: [email protected]
Received November 07, 2011; Accepted December 06, 2011; Published December 10, 2011
Citation: Silva RA, Gregori NZ (2011) Intravitreal Ranibizumab for Macular Edema Secondary to Juxtafoveal Retinal Telangiectasia Type 1A. J Clinic Experiment Ophthalmol 2:195. doi:10.4172/2155-9570.1000195
Copyright: © 2011 Silva RA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
 

Abstract

Purpose: To describe the clinical, angiographic, and optical coherence tomography (OCT) findings of a patient with cystoid macular edema (CME) in juxtafoveal retinal telangiectasis (JXT) treated with intravitreal ranibizumab injections.
 
Methods: In the setting of a tertiary referral center, a patient with a long history of Leber’s miliary aneurysms was later diagnosed with ipsilateral juxtafoveal retinal telangiectasis (JXT) type 1A with associated CME. The patient was treated with eight intravitreal injections of 0.5 mg of ranibizumab and followed with examination and Spectral-Domain Optical Coherence Tomography (OCT) for 14 months.
 
Results:
At baseline, fluorescein angiography demonstrated macular telangiecatasis and aneurysms with late leakage. The OCT showed a large area of intraretinal fluid in the area of telangiectasis. CME resolved after the first intravitreal ranibizumab injection and the vision gradually improved from 20/50 to 20/20−1 over 5 months. Repeat ranibizumab injections were required to keep the macula dry over 14 months. No adverse events were noted.
 
Conclusions: Intravitreal ranibizumab injections resulted in restoration of macular architecture and vision improvement in a patient with JXT type 1A. Ranibizumab should be considered as a treatment option in this condition.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords